The Egyptian Journal of Internal Medicine最新文献

{"title":"An analysis of fatal adverse conditions in temporal association of COVID-19 vaccination to boost the safety of vaccination for COVID-19.","authors":"Shahnawaz Muslim,&nbsp;Gulam Mustafa,&nbsp;Nasrin Nasrin,&nbsp;Aaisha Firdaus,&nbsp;Shambhu Kumar Singh","doi":"10.1186/s43162-023-00191-7","DOIUrl":"https://doi.org/10.1186/s43162-023-00191-7","url":null,"abstract":"<p><p>SARS-CoV-2, the causative agent of COVID-19, claimed multiple lives in a very short span of time. Seeing the urgency of situation, vaccines were developed in hitherto unseen time frame. Vaccines definitely passed the test of safety and efficacy in clinical trials, but post mass vaccination data revealed cases of fatal adverse conditions in the temporal association of vaccination. The temporal association does not guarantee that the fatality is due to vaccination, but at the same time, it does create a concern. To overcome this concern and improve the safety of vaccination, we reviewed literature and collected data of 15 studies comprising of total 22 cases of fatal adverse condition/death in the temporal association of COVID-19 vaccination. Analysis of these data shows that many persons (40.90%) who succumbed were previously healthy individuals. All those who died developed symptoms or were admitted to hospital within a period of 3 weeks after vaccination. 86.36% cases of death took place within a period of 3 weeks after vaccination/presentation/admission/intervention. Complications which lead to death were CVST, thrombocytopenia/thrombosis /VITT, DIC and haemorrhage in 81.18% of cases. 81.81% cases of death were noted in the temporal association with ChAdOx1 nCoV-19 vaccine. 68.18% persons developed symptoms after first dose. Death was more common in females (59.09%), and the most commonly affected age group was 20 to 60 years (86.36%). Knowledge of fatal adverse conditions in the temporal association of vaccination will help to tackle these situations well and improve the safety of vaccination drive further.</p>","PeriodicalId":22465,"journal":{"name":"The Egyptian Journal of Internal Medicine","volume":"35 1","pages":"11"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903264/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10708924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Extra-long treatment of MDR-TB osteomyelitis of humerus due to neurotoxicity from the 2nd-line drugs: a case report.","authors":"Naser Naser,&nbsp;Habib Abdulla,&nbsp;Husain Kadhem","doi":"10.1186/s43162-023-00225-0","DOIUrl":"10.1186/s43162-023-00225-0","url":null,"abstract":"<p><p>Infection with tuberculosis (TB) still considered a leading infectious cause of death, osteomyelitis TB rare entity, and being extraspinal MDR-TB make it very rare case; most of experience in treating osteomyelitis TB was derived from pulmonary TB experience, and we present a case of humerus MDR-TB that was treated for 5 years, with several interruption due to side effect and other causes.</p>","PeriodicalId":22465,"journal":{"name":"The Egyptian Journal of Internal Medicine","volume":"35 1","pages":"41"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262133/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9662427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Severe lupus after two years of hemodialysis: It exists and can be serious.","authors":"Marouane Jabrane,&nbsp;Mohammed Bouchoual,&nbsp;Mohamed Arrayhani","doi":"10.1186/s43162-023-00208-1","DOIUrl":"https://doi.org/10.1186/s43162-023-00208-1","url":null,"abstract":"<p><p>Progression of lupus nephropathy (LN) to end-stage renal disease is a serious complication and requires subsequent replacement therapy. Lupus disease activity is extinguished in chronic hemodialysis. We report the observation of a 35-year-old female patient, in conventionnel hemodialysis for two years (chronic glomerulonephritis), admitted to the emergency room for convulsions, left flaccid tenderness, cutaneous-mucosal pallor and altered general condition evolving since three days before her admission. we also observed a spontaneous ecchymotic lesions on the right arm. Echodoppler of the right upper extremity was in favor of a partially thrombosed aneurysm of the right brachial artery. The biological workup showed pancytopenia, the requested immunological workup showed a low complement C₃, a positive level of anti-DNA antibodies. The patient was treated as severe lupus flare: Bolus of methylprednisolone, followed by oral administration, associated with Mycophenolate mofétil (MMF) at a dose of 1 g/d. The evolution was favorable on the clinical, biological and radiological levels. Systemic lupus erythematous (SLE) can occur even after several years of hemodialysis and sometimes in a severe form, pushing the clinician to think of this pathology in the presence of evocative signs.</p>","PeriodicalId":22465,"journal":{"name":"The Egyptian Journal of Internal Medicine","volume":"35 1","pages":"24"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063328/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9253207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A case of reinfection with a different variant of SARS-CoV-2: case report.","authors":"Nagashige Shimada,&nbsp;Masahiro Shinoda,&nbsp;Hiroaki Takei,&nbsp;Yuto Yoshida,&nbsp;Masashi Nishimura,&nbsp;Mio Kousaka,&nbsp;Miwa Morikawa,&nbsp;Takashi Sato,&nbsp;Hiroto Matsuse,&nbsp;Masaharu Shinkai","doi":"10.1186/s43162-023-00194-4","DOIUrl":"https://doi.org/10.1186/s43162-023-00194-4","url":null,"abstract":"<p><strong>Background: </strong>Coronavirus disease 2019 (COVID-19) was previously thought to have a low reinfection rate, but there are concerns that the reinfection rate will increase with the emergence and spread of mutant variants. This report describes the case of a 36-year-old, non-immunosuppressed man who was infected twice by two different variants of COVID-19 within a relatively short period.</p><p><strong>Case presentation: </strong>A 36-year-old Japanese man with no comorbidities was infected with the E484K variant (R.1 lineage) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Symptoms were mild and improved with symptomatic treatment alone. About four months later he presented to another outpatient department with high fever and headache. We diagnosed him as infected with the Alpha variant (B.1.1.7) of SARS-CoV-2 based on SARS-CoV-2 real-time reverse transcription polymerase chain reaction testing (RT-PCR). The patient was hospitalized with high fever. The patient received treatment in the form of anti-inflammatory therapy with corticosteroid and antibacterial chemotherapy. The patient improved without developing severe disease.</p><p><strong>Conclusion: </strong>Concerns have been raised that the reinfection rate of COVID-19 will increase with the emergence of mutant variants. Particularly in mild cases, adequate amounts of neutralizing antibodies may not be produced, and reinfection may thus occur. Continued attention to sufficient infection control is thus essential.</p>","PeriodicalId":22465,"journal":{"name":"The Egyptian Journal of Internal Medicine","volume":"35 1","pages":"13"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907179/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9267556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of the healthcare-associated infections in intensive care units in Turkey before and during COVID-19.","authors":"Sema Sarı,&nbsp;Ferhat Arslan,&nbsp;Sema Turan,&nbsp;Tuğçe Mengi,&nbsp;Handan Ankaralı,&nbsp;Ahmet Sarı,&nbsp;Mine Altınkaya Çavuş,&nbsp;Çilem Bayındır Dicle,&nbsp;Derya Tatlısuluoğlu,&nbsp;Hüseyin Arıcan,&nbsp;Yahya Tahta,&nbsp;Haluk Vahaboğlu","doi":"10.1186/s43162-023-00215-2","DOIUrl":"https://doi.org/10.1186/s43162-023-00215-2","url":null,"abstract":"<p><strong>Background: </strong>Secondary bacterial infections are an important cause of mortality in patients with coronavirus disease 2019 (COVID-19). All healthcare providers acted with utmost care with the reflex of protecting themselves during the COVID-19 period. We aimed to compare the rates of ventilator-associated pneumonia (VAP) and bloodstream infections (BSIs) in our intensive care units (ICUs) before and during the COVID-19 outbreak surges.</p><p><strong>Methods: </strong>This multicenter, retrospective, cross-sectional study was performed in six centers in Turkey. We collected the patient demographic characteristics, comorbidities, reasons for ICU admission, mortality and morbidity scores at ICU admission, and laboratory test data.</p><p><strong>Results: </strong>A total of 558 patients who required intensive care from six centers were included in the study. Four hundred twenty-two of these patients (males (62%), whose mean age was 70 [IQR, 58-79] years) were followed up in the COVID period, and 136 (males (57%), whose mean age was 73 [IQR, 61-82] years) were followed up in the pre-COVID period. BSI and VAP rates were 20.7 (19 events in 916 patient days) and 17 (74 events in 4361 patient days) with a -3.8 difference (<i>P</i> = 0.463), and 33.7 (31 events in 919 patient days) and 34.6 (93 events in 2685 patient days) with a 0.9 difference (<i>P</i> = 0.897), respectively. The mortality rates were 71 (52%) in pre-COVID and 291 (69%) in COVID periods.</p><p><strong>Conclusion: </strong>Protective measures that prioritize healthcare workers rather than patients and exceed standard measures made no difference in terms of reducing mortality.</p>","PeriodicalId":22465,"journal":{"name":"The Egyptian Journal of Internal Medicine","volume":"35 1","pages":"30"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108807/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9757357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Fungal brain abscesses caused by <i>Acremonium</i> species.","authors":"Hamdy Ibrahim,&nbsp;Mostafa ALfishawy,&nbsp;Attaa Ali,&nbsp;Safwat Abdel Maksod,&nbsp;Magdy Khorshed,&nbsp;Hanan Rady,&nbsp;Ahmed Alsisi,&nbsp;Adel Mohamed,&nbsp;Omar Alkassas,&nbsp;Marwa Haron,&nbsp;Suzan Saied","doi":"10.1186/s43162-022-00183-z","DOIUrl":"https://doi.org/10.1186/s43162-022-00183-z","url":null,"abstract":"<p><p>Unusual fungal agents that exist environmentally as saprophytes can often lead to opportunistic infections, hyalohyphomycosis is a group of fungal infections caused by fungi characterized by hyaline septate hyphae and can infect both immunocompetent as well as immunocompromised patients, and <i>Acremonium</i> has drawn the attention of clinicians and microbiologists, as a potential pathogen in patients with and without underlying risk factors. It has also been increasingly implicated in systemic fungal diseases. Herein, we describe a case presentation of an immunocompromised patient with fungal brain abscesses due to <i>Acremonium</i> species.</p>","PeriodicalId":22465,"journal":{"name":"The Egyptian Journal of Internal Medicine","volume":"35 1","pages":"5"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884595/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10661214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The effect of different direct antivirals on hepatic steatosis in nondiabetic and naïve hepatitis C-infected Egyptian patients.","authors":"Ahmed El-Ghandour,&nbsp;Tarek Youssif,&nbsp;Wesam Ibrahim,&nbsp;Hoda Ahmed Abdelsattar,&nbsp;Somia Abd Elhamid Bawady,&nbsp;Mariam Wagih,&nbsp;Sarah El-Nakeep","doi":"10.1186/s43162-023-00197-1","DOIUrl":"https://doi.org/10.1186/s43162-023-00197-1","url":null,"abstract":"<p><strong>Background: </strong>Hepatitis C is associated with metabolic effects and fatty liver disease. The effect of different direct antivirals on the liver steatosis, and the metabolic profile, still needs to be established. The aim of this study is to determine the effect of achieving the sustained virological response after 12 weeks (SVR-12 weeks) with different combinations of direct antiviral drugs, on the hepatic steatosis, and fibrosis presented by laboratory and transient elastography parameters. Our study population is nondiabetic, chronically infected HCV Egyptian patients and naïve to any form of HCV treatment.</p><p><strong>Methods: </strong>This cohort study was carried on 100 nondiabetic HCV treatment-naïve patients attending the Hepatology Clinic, in the Gastroenterology and Hepatology Department, Ain Shams University, and Kobry El Koba Military Hospital. The patients were divided into four groups according to their treatment regimens as follows: group A: 25 patients who received sofosbuvir (400 mg) and daclatasvir (60 mg) daily for 12 weeks; group B: 25 patients who received sofosbuvir (400 mg) and ledipasvir (90 mg) daily for 12 weeks; group C: 25 patients who received ombitasvir (12.5 mg), paritaprevir (75 mg), and ritonavir (50 mg) daily for 12 weeks; and group D: 25 patients who received sofosbuvir (400 mg) and simeprevir (150 mg) daily for 12 weeks. All patients were subjected to the following investigations: HCV quantitative PCR before and after 12 weeks of treatment, clinical and laboratory metabolic evaluation including alfa-fetoprotein level, thyroid profile assessment, ferritin level, pelvi-abdominal ultrasound, and FibroScan examination.</p><p><strong>Results: </strong>All patients achieved SVR after 12 weeks. FibroScan median decreased (<i>P</i> < 0.001) from 19.29 ± 6.97 kPa at baseline to 14.15 ± 6.48 kPa at SVR12. NAFLD score median increased from 1.88 (1.49-2.22) at baseline to 2.01 (1.61-2.33) after 12 weeks of treatment. The highest level of NAFLD score was in group C, and the lowest was in group B. The BMI mean decreased from 28.31 ± 1.53 at baseline to 28.07 ± 1.52 at SVR12. HbA1C level mean decreased from 5.73 ± 0.23 at baseline to 5.40 ± 0.24 at SVR12. In addition, liver enzymes, cholesterol, triglycerides, APRI score (AST-platelet ratio index), and HBA1C decreased after 12-week treatment with a statistically significant difference, while the mean LDL increased after 12 weeks of treatment.</p><p><strong>Conclusions: </strong>DAAs affect the metabolic profile of the treated patients. There is a noticed improvement in the FibroScan, NAFLD score, and lipid profile after achieving the SVR-12 weeks. However, LDL is increased after viral cure, mostly due to viral-host molecular interaction.</p>","PeriodicalId":22465,"journal":{"name":"The Egyptian Journal of Internal Medicine","volume":"35 1","pages":"12"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922615/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9329357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hospital at home: emergence of a high-value model of care delivery.","authors":"Sai Gautham Kanagala, Vasu Gupta, Sunita Kumawat, Fnu Anamika, Brian McGillen, Rohit Jain","doi":"10.1186/s43162-023-00206-3","DOIUrl":"10.1186/s43162-023-00206-3","url":null,"abstract":"<p><strong>Background: </strong>With increasing healthcare demands for acute illness in patients especially in the times of pandemic, healthcare organizations require modern solutions. Hospital at home (HaH) is one such tool that has the potential to solve these problems without compromising the care of the patients.</p><p><strong>Main body: </strong>Hospitals have been the conventional setting for managing acute sickness patients; however, it could be a very challenging environment for a few patients, especially for the older population who are highly susceptible to hospital-acquired infections. Health care in a hospital setting can also be very expensive, as it often involves a lot of healthcare professionals providing care. HaH service can provide the same quality of care expected in traditional settings.</p><p><strong>Conclusions: </strong>The median length of stay and the rate of readmissions were lower in people under HaH care. Compared with patients in a hospital setting, patients in HaH had better clinical outcomes. HaH unit provides an integrated, flexible, easy-to-scale platform that can be cost-effectively adapted to high-demand situations.</p>","PeriodicalId":22465,"journal":{"name":"The Egyptian Journal of Internal Medicine","volume":"35 1","pages":"21"},"PeriodicalIF":1.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023005/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9245934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Sudden cardiac death in the adolescent population: a narrative review.","authors":"Meet A Patel,&nbsp;Anisha Malhotra,&nbsp;Franck H Moussinga Mpondo,&nbsp;Vasu Gupta,&nbsp;Rahul Jain,&nbsp;Sachin Gupta,&nbsp;Rohit Jain","doi":"10.1186/s43162-023-00222-3","DOIUrl":"10.1186/s43162-023-00222-3","url":null,"abstract":"<p><strong>Background: </strong>Death from unexpected circulatory arrest within 60 min of onset of symptom is known as sudden cardiac death (SCD). In spite of the advancement in treatment and prevention strategies, SCD remains the most common cause of death worldwide especially in the young.</p><p><strong>Main body: </strong>This review focuses on highlighting how different cardiovascular diseases contribute to SCD. We discuss the clinical symptoms that the patient experience prior to sudden cardiac arrest and the treatment strategies including pharmacological and surgical treatment.</p><p><strong>Conclusions: </strong>We conclude that since there are many causes of SCD and very few treatment options, prevention strategies, early detection, and resuscitation of those at greatest risk is important.</p>","PeriodicalId":22465,"journal":{"name":"The Egyptian Journal of Internal Medicine","volume":"35 1","pages":"36"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195126/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9871005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diagnostic challenge of dyspnea in the context of the COVID-19 pandemic wave: a case report.","authors":"Zamelina Angela Razafindrasoa,&nbsp;Sonia Marcelle Razafimpihanina,&nbsp;Marie Odette Rasoafaranirina,&nbsp;Fidy Arnauld Martin,&nbsp;Finaritra Princy Parfait Andriamahenina,&nbsp;Diamondra Ombanjanahary Andriarimanga,&nbsp;Jocelyn Robert Rakotomizao,&nbsp;Harison Michel Tiaray,&nbsp;Joëlson Lovaniaina Rakotoson,&nbsp;Rondro Nirina Raharimanana","doi":"10.1186/s43162-023-00192-6","DOIUrl":"https://doi.org/10.1186/s43162-023-00192-6","url":null,"abstract":"<p><strong>Background: </strong>Since its discovery, COVID-19 has often been the first diagnosis of dyspnea and asthenia, especially during the pandemic waves. However, it is not always COVID-19. We report a particular case of a late-diagnosed HIV-positive patient in Madagascar.</p><p><strong>Case presentation: </strong>A 21-year-old male patient was admitted to a hospital center in Antananarivo for dyspnea and poor general condition. Physical examination revealed hypoxemia of 85% on room air. His chest X-ray showed bilateral reticular-micronodular opacities. He was suspected and treated for COVID-19. On the 15th day of hospitalization, HIV-1 infection complicated by probable pneumocystis was diagnosed. On the other hand, a multimetastatic testicular cancer was also suspected. The patient died after a few hours of hospitalization in the intensive care unit.</p><p><strong>Conclusion: </strong>This was a case of an HIV-positive patient belatedly diagnosed in the complications stage during the COVID-19 pandemic wave. The investigation of the differential diagnoses remains crucial to avoid serial misdiagnosis and to adjust therapeutic management.</p>","PeriodicalId":22465,"journal":{"name":"The Egyptian Journal of Internal Medicine","volume":"35 1","pages":"9"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887561/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10665994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}